{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:25:57Z","timestamp":1791231957270,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbi.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T15:04:47Z","timestamp":1738508687000},"page":"452-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis"],"prefix":"10.1016","volume":"125","author":[{"given":"Jacob","family":"Ahlberg Weidenfors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vytautas","family":"Gri\u0161ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aist\u0117","family":"Pranckevi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolita","family":"Pakalnien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Atlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Franz\u00e9n-R\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Piehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auks\u0117","family":"Mickien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Engberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly","family":"Schwieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2025.02.005_b0005","doi-asserted-by":"crossref","DOI":"10.4137\/IJTR.S13256","article-title":"Sustained elevation of kynurenic acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis","volume":"6","author":"Atlas","year":"2013","journal-title":"Int. J. Tryptophan Res."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbi.2006.02.005","article-title":"Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid","volume":"21","author":"Atlas","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2025.02.005_b0015","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.bbi.2025.02.005_b0020","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41375-023-01840-0","article-title":"Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation","volume":"37","author":"Boberg","year":"2023","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bbi.2025.02.005_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040796","article-title":"Comparison of clinical, laboratory and immune characteristics of the monophasic and biphasic course of tick-borne encephalitis","volume":"9","author":"Bogovi\u010d","year":"2021","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.bbi.2025.02.005_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7110514","article-title":"Inflammatory immune responses in patients with tick-borne encephalitis: dynamics and association with the outcome of the disease","volume":"7","author":"Bogovi\u010d","year":"2019","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.bbi.2025.02.005_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050731","article-title":"Inflammatory immune responses in the pathogenesis of tick-borne encephalitis","volume":"8","author":"Bogovi\u010d","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ttbdis.2017.12.001","article-title":"The long-term outcome of tick-borne encephalitis in Central Europe","volume":"9","author":"Bogovi\u010d","year":"2018","journal-title":"Ticks Tick-borne Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0045","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1038\/s41598-021-89335-9","article-title":"Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder","volume":"11","author":"Cathomas","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-020-00421-4","article-title":"Increased serum QUIN\/KYNA is a reliable biomarker of post-stroke cognitive decline","volume":"16","author":"Cogo","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-\u03b3?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.bbi.2025.02.005_b0060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/acn3.51825","article-title":"The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC","volume":"10","author":"Cysique","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"13","key":"10.1016\/j.bbi.2025.02.005_b0065","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S0950268818002005","article-title":"Sequelae of tick-borne encephalitis in retrospective analysis of 1072 patients","volume":"146","author":"Czupryna","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.bbi.2025.02.005_b0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.bbi.2025.02.005_b0075","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor \u03b6-chain and induce a regulatory phenotype in naive T Cells1","volume":"176","author":"Fallarino","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2025.02.005_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3940(84)90050-8","article-title":"Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid","volume":"48","author":"Foster","year":"1984","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.bbi.2025.02.005_b0085","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1176\/appi.ajp.2007.07010089","article-title":"Functional Co-primary measures for clinical trials in schizophrenia: results from the MATRICS psychometric and standardization study","volume":"165","author":"Green","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2025.02.005_b0095","first-page":"1","article-title":"Long-term neurological and neurocognitive impairments after tick-borne encephalitis in Lithuania\u2014A prospective study","author":"Gri\u0161ka","year":"2024","journal-title":"Infect. Dis."},{"issue":"19","key":"10.1016\/j.bbi.2025.02.005_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910615","article-title":"Selected biomarkers of tick-borne encephalitis: a review","volume":"22","author":"Gudowska-Sawczuk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbi.2025.02.005_b0105","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2025.02.005_b0110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","article-title":"Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease","volume":"17","author":"Guidetti","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2025.02.005_b0115","series-title":"Developments in Tryptophan and Serotonin Metabolism","first-page":"105","article-title":"Expression of the kynurenine pathway enzymes in human microglia and macrophages","author":"Guillemin","year":"2003"},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0120","first-page":"6029","article-title":"Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid","volume":"1","author":"G\u00fcnther","year":"2011","journal-title":"Infect. Ecol. Epidemiol."},{"issue":"3","key":"10.1016\/j.bbi.2025.02.005_b0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00365549609027160","article-title":"A 10-year follow-up study of tick-borne encephalitis in the stockholm area and a review of the literature: need for a vaccination strategy","volume":"28","author":"Haglund","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.bbi.2025.02.005_b0130","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014Pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(92)90214-6","article-title":"Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and \u03b22-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients","volume":"40","author":"Heyes","year":"1992","journal-title":"J. Neuroimmunol."},{"issue":"19","key":"10.1016\/j.bbi.2025.02.005_b0140","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits \u03b17 nicotinic receptor activity and increases non-\u03b17 Nicotinic receptor expression: physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12936-017-1954-1","article-title":"Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria","volume":"16","author":"Holmberg","year":"2017","journal-title":"Malar. J."},{"issue":"16","key":"10.1016\/j.bbi.2025.02.005_b0150","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/jnr.21799","article-title":"Induction of the kynurenine pathway by neurotropic influenza a virus infection","volume":"86","author":"Holtze","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.bbi.2025.02.005_b0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2796.2012.02539.x","article-title":"Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitis","volume":"272","author":"Holtze","year":"2012","journal-title":"J. Intern. Med."},{"issue":"11","key":"10.1016\/j.bbi.2025.02.005_b0160","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994\u201398: A prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(94)90504-5","article-title":"Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum","volume":"668","author":"Kalisch","year":"1994","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.icb.7100012","article-title":"Immunopathology of flavivirus infections","volume":"85","author":"King","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0175","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the l-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2025.02.005_b0180","doi-asserted-by":"crossref","unstructured":"Kohlmaier, B., Schweintzger, N. A., Sagmeister, M. G., \u0160vendov\u00e1, V., Kohlf\u00fcrst, D. S., Sonnleitner, A., Leitner, M., Berghold, A., Schmiedberger, E., Fazekas, F., Pichler, A., Rejc-Marko, J., R\u016f\u017eek, D., Dufkov\u00e1, L., \u010cejkov\u00e1, D., Husa, P., P\u00fdchov\u00e1, M., Krbkov\u00e1, L., Chmel\u00edk, V., \u2026 the EU-TICK-BO STUDY GROUP. (2021). Clinical Characteristics of Patients with Tick-Borne Encephalitis (TBE): A European Multicentre Study from 2010 to 2017. Microorganisms, 9(7), Article 7. .","DOI":"10.3390\/microorganisms9071420"},{"issue":"5","key":"10.1016\/j.bbi.2025.02.005_b0185","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0889-1591(02)00014-4","article-title":"The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen","volume":"16","author":"Lestage","year":"2002","journal-title":"Brain Behav. Immun."},{"issue":"9627","key":"10.1016\/j.bbi.2025.02.005_b0190","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","article-title":"The kynurenine system and immunoregulation","volume":"119","author":"M\u00e1ndi","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2025.02.005_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702048","article-title":"Inhibition of tryptophan catabolism is associated with neuroprotection during zika virus infection","volume":"12","author":"Marim","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-6-1","article-title":"Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe","volume":"6","author":"Medlock","year":"2013","journal-title":"Parasit. Vectors"},{"issue":"10","key":"10.1016\/j.bbi.2025.02.005_b0210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"Ido expression by dendritic cells: Tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2025.02.005_b0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/342059","article-title":"Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis","volume":"35","author":"Mickien\u0117","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0220","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41598-023-28135-9","article-title":"A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium","volume":"13","author":"Midttun","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbi.2025.02.005_b0225","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.euroneuro.2013.03.008","article-title":"Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine","volume":"23","author":"Molteni","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2025.02.005_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.998397","article-title":"Peripheral interleukin-6-associated microglial QUIN elevation in basolateral amygdala contributed to cognitive dysfunction in a mouse model of postoperative delirium","volume":"9","author":"Mu","year":"2022","journal-title":"Front. Med."},{"issue":"6704","key":"10.1016\/j.bbi.2025.02.005_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk4898","article-title":"A metabolic dependency of EBV can be targeted to hinder B cell transformation","volume":"385","author":"M\u00fcller-Durovic","year":"2024","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bbi.2025.02.005_b0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.02.005_b0245","doi-asserted-by":"crossref","DOI":"10.1177\/11786469241245323","article-title":"Kynurenine metabolites in CSF and plasma in healthy males","volume":"17","author":"Orhan","year":"2024","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.bbi.2025.02.005_b0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","article-title":"Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity","volume":"507","author":"Palus","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.bbi.2025.02.005_b0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2025.02.005_b0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90749-W","article-title":"Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in: Huntington\u2019s Disease","volume":"144","author":"Pearson","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbi.2025.02.005_b0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jir.1986.6.267","article-title":"Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts","volume":"6","author":"Pfefferkorn","year":"1986","journal-title":"J. Interferon Res."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41386-023-01681-6","article-title":"Kynurenic acid: Translational perspectives of a therapeutically targetable gliotransmitter","volume":"49","author":"Pocivavsek","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0280","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1038\/s41598-019-52570-2","article-title":"Encephalitis and aseptic meningitis: Short-term and long-term outcome, quality of life and neuropsychological functioning","volume":"9","author":"Quist-Paulsen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2025.02.005_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines","volume":"164","author":"Ruzek","year":"2019","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2008.11.023","article-title":"CD8+ T-cells mediate immunopathology in tick-borne encephalitis","volume":"384","author":"R\u016f\u017eek","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.bbi.2025.02.005_b0300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"4582","key":"10.1016\/j.bbi.2025.02.005_b0305","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bbi.2025.02.005_b0310","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4155\/bio-2019-0303","article-title":"A novel, robust method for quantification of multiple kynurenine pathway metabolites in the cerebrospinal fluid","volume":"12","author":"Schwieler","year":"2020","journal-title":"Bioanalysis"},{"issue":"10","key":"10.1016\/j.bbi.2025.02.005_b0315","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/mp.2015.186","article-title":"A genome-wide association study of kynurenic acid in cerebrospinal fluid: Implications for psychosis and cognitive impairment in bipolar disorder","volume":"21","author":"Sellgren","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2025.02.005_b0320","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2025.02.005_b0325","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2025.02.005_b0330","series-title":"Translational Interventional Radiology","first-page":"245","article-title":"Chapter 50 - historical control: design, measures, and classic example","author":"Taghipour","year":"2023"},{"key":"10.1016\/j.bbi.2025.02.005_b0335","doi-asserted-by":"crossref","DOI":"10.1177\/1178646920978241","article-title":"Quantification of plasma kynurenine metabolites following one bout of sprint interval exercise","volume":"13","author":"Trepci","year":"2020","journal-title":"Int. J. Tryptophan Res."},{"issue":"2","key":"10.1016\/j.bbi.2025.02.005_b0340","first-page":"453","article-title":"Tick-borne encephalitis","volume":"34","author":"Valarcher","year":"2015","journal-title":"Revue Scientifique Et Technique (international Office of Epizootics)"},{"issue":"9","key":"10.1016\/j.bbi.2025.02.005_b0345","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.bbi.2025.02.005_b0350","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41380-018-0076-7","article-title":"Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice","volume":"24","author":"Walker","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2025.02.005_b0355","first-page":"91","article-title":"CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation","author":"Yan","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.bbi.2025.02.005_b0360","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.bbi.2025.02.005_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115137","article-title":"Itaconate alleviates \u03b22-microglobulin-induced cognitive impairment by enhancing the hippocampal amino-\u03b2-carboxymuconate-semialdehyde-decarboxylase\/picolinic acid pathway","volume":"202","author":"Zhou","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2025.02.005_b0370","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1\u03b2: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:52:00Z","timestamp":1741593120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":74,"alternative-id":["S0889159125000431"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.02.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of the kynurenine pathway is related to persistent cognitive impairment in tick-borne encephalitis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}